15-keto-13-14-dihydroprostaglandin-f2alpha and Pregnancy--Ectopic

Eight experiments were conducted to examine the influence of the conceptus on luteal function in mice. In uterine intact pseudopregnant mice, exogenous treatment with placental extracts or pregnant mouse plasma from Day 8 or Day 10 of gestation did not prolong the life span of the corpora lutea (CL). The interestrous interval (IEI) of hysterectomized pseudopregnant mice was extended by treatment with Day 10 placental extract and was accompanied by elevated plasma progesterone, consistent with the luteotropic nature of the Day 10 conceptus. The IEI of uterine intact pseudopregnant mice was prolonged by the presence of ectopically developing blastocysts and was further extended by a treatment with Day 10 placental extracts but not by treatment with Day 8 placental extracts. Although the ectopic blastocyst delayed the effect of the uterine luteolytic mechanism, there was no indication of luteotropic activity: the ectopic blastocysts were unable to activate the CL of the estrous cycle. In addition, plasma progesterone and 13,14-dihydro-15-keto-prostaglandin F2 alpha (PGFM) were measured in pseudopregnant, hysterectomized pseudopregnant and pregnant mice on Day 2 through 13 post-mating. The results of these experiments suggest a two-step mechanism in prolonging luteal function during pregnancy which involves two different substances. This mechanism involves an initial signal from the conceptus which blocks the uterine luteolytic mechanism and a subsequent luteotropic stimulus from the Day 10 conceptus which extends luteal life span to approximately the length of gestation.

Topics: Animals; Blastocyst; Corpus Luteum; Corpus Luteum Maintenance; Dinoprost; Estrus; Female; Mice; Models, Biological; Placenta; Pregnancy; Pregnancy Maintenance; Pregnancy, Ectopic; Progesterone; Prostaglandins F; Pseudopregnancy; Uterus